BioSpace Collaborative

Academic/Biomedical Research
News & Jobs
Biotechnology and Pharmaceutical Channel Medical Device and Diagnostics Channel Clinical Research Channel BioSpace Collaborative    Job Seekers:  Register | Login          Employers:  Register | Login  

NEWSLETTERS
Free Newsletters
Archive
My Subscriptions

NEWS
News by Subject
News by Disease
News by Date
PLoS
Search News
Post Your News
JoVE

CAREER NETWORK
Job Seeker Login
Most Recent Jobs
Search Jobs
Post Resume
Career Fairs
Career Resources
For Employers

HOTBEDS
Regional News
US & Canada
  Biotech Bay
  Biotech Beach
  Genetown
  Pharm Country
  BioCapital
  BioMidwest
  Bio NC
  BioForest
  Southern Pharm
  BioCanada East
  C2C Services & Suppliers™
Europe
Asia

DIVERSITY

PROFILES
Company Profiles

INTELLIGENCE
Research Store

INDUSTRY EVENTS
Research Events
Post an Event
RESOURCES
Real Estate
Business Opportunities

By Industry | By Industry Segment | By Services and Suppliers | By Location | By Hotbed | Profile Search
 Company Profile

 

BioAlliance Pharma 

59, Boulevard du Général Valin

Paris    75015  France
Phone: 33-0-145-5876-00 Fax: 33-0-145-5808-81


SEARCH JOBS

View Clinical Trials from BioPharm Insight









 Company News
BioAlliance Pharma: Approval Of Onxeo’s Admission To Secondary Listing And Trading On NASDAQ OMX Copenhagen 7/24/2014 10:45:18 AM
BioAlliance Pharma Announces The Launch Of Sitavig® In The United States By Its Partner Innocutis 7/21/2014 12:28:33 PM
BioAlliance Pharma Strengthens Its Financial Resources With The Support Of Its Top Shareholder 7/18/2014 11:10:01 AM
BioAlliance Pharma And TopoTarget A/S Shareholders Approve Proposed Cross-Border Merger To Create Onxeo 6/30/2014 10:42:09 AM
BioAlliance Pharma Release: Execution Of A License Agreement With EMS For Sitavig® In Brazil 6/25/2014 10:41:54 AM
BioAlliance Pharma Has Received Pre-Approval For The Secondary Listing Of The Shares Of The Merged Company On NASDAQ OMX Copenhagen 6/20/2014 11:10:24 AM
BioAlliance Pharma, TopoTarget A/S To Merge, Combined Entity To Be Named Onxeo 5/22/2014 8:50:36 AM
BioAlliance Pharma: Livatag® Receives Fast Track Designation From The FDA For The Treatment Of Primary Liver Cancer 5/20/2014 8:43:07 AM
BioAlliance Pharma SA: Quarterly Information As Of March 31, 2014 5/1/2014 2:38:37 PM
BioAlliance Pharma Release: Quarterly Information As Of March 31, 2014 4/30/2014 12:53:40 PM
12345678910...